Top Markets
Coin of the day
Pardes Biosciences, Inc. Pardes Biosciences, Inc.

Pardes Biosciences, Inc.

PRDS
Rangering i aksjer #20774
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated... Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to identifying, developing, and marketing groundbreaking treatments. The company's core objective is to improve outcomes for patients battling life-threatening illnesses. Its primary investigational therapy, PBI-0451, is currently progressing through clinical development with the aim of both treating and preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and their related health issues. Established in 2020, Pardes Biosciences maintains its corporate headquarters in Carlsbad, California.
Aksjekurs
$2.16
Sist synkronisert: 2023-09-08
Markedsverdi
$122.36M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Pardes Biosciences, Inc. (PRDS)

Kategori

Utbytteavkastning for Pardes Biosciences, Inc. (PRDS)
Pardes Biosciences, Inc. (aksjesymbol: PRDS) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Pardes Biosciences, Inc. (PRDS) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
Selskap Utbytteavkastning Land
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH